The yin and yang of light: A cardiovascular point of view

Abstract

Get full access to this article

View all access options for this article.

References

Hart

Norval

Byrne

et al.

Exposure to ultraviolet radiation in the modulation of human diseases. Annu Rev Pathol. Epub ahead of print 20 August 2018. DOI: 10.1146/annurev-pathmechdis-012418-012809.

Rostand

. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997; 30: 150–156.

Modesti

Morabito

Massetti

et al.

Seasonal blood pressure changes: An independent relationship with temperature and daylight hours. Hypertension 2013; 61: 908–914.

Kent

Cushman

Howard

et al.

Sunlight exposure and cardiovascular risk factors in the REGARDS study: A cross-sectional split-sample analysis. BMC Neurol 2014; 14: 133–133.

Liu

Fernandez

Hamilton

et al.

UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J Invest Dermatol 2014; 134: 1839–1846.

Oplander

Volkmar

Paunel-Gorgulu

et al.

Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ Res 2009; 105: 1031–1040.

Beveridge

Struthers

Khan

et al.

Effect of vitamin D supplementation on blood pressure: A systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med 2015; 175: 745–754.

Opländer

Deck

Volkmar

et al.

Mechanism and biological relevance of blue-light (420–453 nm)-induced nonenzymatic nitric oxide generation from photolabile nitric oxide derivates in human skin in vitro and in vivo. Free Radic Biol Med 2013; 65: 1363–377.

Stern

Broja

Sansone

et al.

Blue light exposure decreases systolic blood pressure, arterial stiffness, and improves endothelial function in humans. Eur J Prev Cardiol. 25: 1875–1883.

10.

Kotseva

De Bacquer

De Backer

et al.

on behalf of the EUROASPIRE Investigators. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Cardiol 2016; 23: 2007–2018.